On this page
This entry or formulation may be investigational and may not correspond to an FDA-approved product; safety and efficacy may not have been established. Kairo lists it for identification and record-keeping only.
Overview
Product & regulatory status
The cited study supports further investigation; it does not establish broad treatment equivalence or healthy-person cognitive enhancement.
Proposed pathways remain under study
The human study also measured blood enkephalin activity. A correlation with symptoms is a mechanistic clue, rather than proof that this is the complete pathway responsible for an effect. [1]
What the evidence shows
Small anxiety comparison
A study of 62 patients with generalized anxiety disorder or neurasthenia compared Selank with medazepam. Investigators reported similar anxiety improvement and additional effects on fatigue-related symptoms. It was an active-drug comparison, not a large placebo-confirmed program. [1]
Animal memory findings
A separate experiment examined learning and memory after specific noradrenergic-system injuries in rats. Restoration of performance in that model cannot be transferred directly to routine memory complaints. [2]
What remains unknown
Independent replication, durable symptom benefit, detailed adverse-event estimates, and comparisons with established care remain important gaps.
Safety
Avoid overreading a small study
The accessible clinical abstract gives limited detail on adverse events and effect sizes. It cannot justify calling Selank non-addictive, side-effect-free, or compatible with every psychiatric medication. [1]
Clinical abstract leaves preparation gaps
The anxiety study describes a specific Selank intervention, but the accessible abstract does not establish product stability or storage requirements. Those details should not be invented from the reported symptom response. [1]
Understanding product quality
Compounded drugs are not FDA-approved finished products. Poor preparation can cause contamination or incorrect strength. A catalog entry or a research paper is not a quality assessment of your product. [3]
When to seek urgent help
Severe allergic symptoms such as trouble breathing, throat or tongue swelling, or fainting need immediate help. Call 911 or your local emergency number. This is general emergency information, not a complete list of risks for this compound. [4]
A starting point for discussion
This is not a complete list of adverse effects or interactions. Your health history, other medicines, and the exact formulation matter. Missing safety data is not evidence of safety.
Common questions
Is Selank a substitute for prescribed anxiety treatment?
This guide does not establish that. The small clinical comparison should be discussed in the context of diagnosis, current treatment, and the quality of the available evidence.
Questions for your clinician
Does the evidence match my condition and this exact product? What risks or interactions matter for me? How would we assess whether it is helping?
Sources
- Selank compared with medazepam for anxiety2008 · Original research · PubMed
- Selank in a rat memory impairment model2008 · Original research · PubMed
- Compounding and the FDA: Questions and AnswersFDA · product quality and regulation
- AnaphylaxisMedlinePlus · recognizing an emergency
Educational information, not a recommendation to use a compound. Kairo does not give dosing advice. Review decisions with a licensed healthcare professional.